This is an interesting meta analysis regarding the value of transient elastography and point share wave elastography (VTQ) in the evaluation of liver fibrosis in NAFLD patients. The paper is very detailed but there are some aspects that need clarifications. pSWE is a technique used by several ultrasound manufactures. All the studies included were performed using VTQ (Siemens). This should be presented by the authors. There is not clear if for TE only M probe was used or M and XL probes. This should also be presented. It should be highlighted that these studies included very different populations. The cut off values from these studies are very different for both techniques. This should also be commented. There are small typing and language errors highlighted in the 2 manuscript that need revision. The authors stated that: A total of 20 studies were obtained in the final search. Ten studies met the inclusion criteria for TE [7,16,[22][23][24][25][26][27][28][29][30], and 7 studies met the criteria for pSWE. [21-23, 29, 31-35] But there were 11 studies with TE and 9 with pSWE. Please correct. 
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GENERAL COMMENTS
Summary of paper The Authors carried out a meta-analysis on diagnostic performance of Point shear wave Elastography (pSWE) and Transient Elastography (TE) in order to stage hepatic fibrosis in patients with non-alcoholic fatty liver disease (NAFLD). It was based on nine and eleven studies enrolling 982 and 1753 participants in pSWE and TE respectively. Pooled results showed that pSWE and TE provided precise staging of liver fibrosis in NAFLD. This review covers an important area of research, considering the non-invasive nature of the above diagnostic methods. There are however some aspects to be further clarified. 
Results
-Please provide the list of the 100 excluded articles mentioned (see Figure 1 ) and the main reason(s) for exclusion in a supplementary appendix.
- Tables 1 and 2 4.There are small typing and language errors highlighted in the manuscript that need revision. The authors stated that: Answer: The typing and language errors have been checked and corrected.
5.A total of 20 studies were obtained in the final search. Ten studies met the inclusion criteria for TE [7, 16, [22] [23] [24] [25] [26] [27] [28] [29] [30] , and 7 studies met the criteria for pSWE. [21-23, 29, 31-35] But there were 11 studies with TE and 9 with pSWE. Please correct. Answer: Many thanks for your reminding, the error has been revised.
6. 6.-Were some subgroup analyses/sensitivity analyses foreseen in addition to that reported in the manuscript? if yes, please provide more information on this point. Answer: a sensitivity analysis was conducted in the study to explore the source of the heterogeneity (page 31). We did not perform a subgroup analysis because the number of pSWE studies is restricted (less than 10 paragraphs) and this may lower the reliability of meta-regression if we make.
Results 7.-Please provide the list of the 100 excluded articles mentioned (see Figure 1 ) and the main reason(s) for exclusion in a supplementary appendix. Answer: Done accordingly.
8.
- Tables 1 and 2 should be more informative. The following information for each study should be made available: gender, blinding information, clinical setting, disease prevalence, cross-tabulation (2x2 table) of index test with reference standard and funding Answer: We appreciate the suggestion very much. Tables 1 and 2 have been reset to make them more informative (See Tables 1 and 2 ). We fail to make a cross-tabulation (2x2 table) of index test because we can only extract the data about sensitivity, specificity and ROC curve from original articles and cross-tabulation is needed to be calculated via them. It will be more reasonable to reflect its primitiveness by recoding original data.
9.-Exploratory analysis based on the role of funding and on study quality (high vs low) could be useful in attempting to explain heterogeneity and in discussing study findings. 
GENERAL COMMENTS
The authors have revised their manuscript, incorporating the majority of my suggestions.
I have a few minor suggestions, and I defer to the editors as to whether an additional revision is warranted.
1) The authors have misunderstood my recommendation about the order of presentation of pSWE and TE. The manuscript and figures still are variable in the order of presentation of pSWE and TE. I had recommended that pSWE always be presented first, and TE always be presented second. I defer to the editors if they feel that this is a suggestion worthy of further correction.
2) The dotted lines in the ROC curves have been explained as 95% CI, however, some of the ROC curves have two sets of dotted lines. I suggest that the caption explains what both sets of dotted lines indicate.
3) I suggest adding a legend for all of the acronyms used. 
The Authors addressed the previously outlined issues. The absence of study protocol and of prospective registration should still be described in more detail among the limitations of this metaanalysis.
VERSION 2 -AUTHOR RESPONSE
Reviewer(s)' Comments to Author:
Reviewer: 1
Reviewer Name: Andrew Phelps Institution and Country: UCSF Benioff Children's Hospital
Please state any competing interests: None declared 1) The authors have misunderstood my recommendation about the order of presentation of pSWE and TE. The manuscript and figures still are variable in the order of presentation of pSWE and TE. I had recommended that pSWE always be presented first, and TE always be presented second. I defer to the editors if they feel that this is a suggestion worthy of further correction.
Answer: Many thanks for the recommendation. We have adjusted the order of presentation of pSWE and TE. Now pSWE is always presented first and TE is second throughout manuscript and figures.
Answer: We appreciate your reminding. We have noticed that some ROC curves have two sets of dotted lines which represent confidence interval and prediction interval, respectively. The captions have now been added.
3) I suggest adding a legend for all of the acronyms used.
Answer: Deferring to Prof Phelps's recommendation, we have added a legend for all of acronyms (after the Strengths and Limitations section). However, we found that there was no legend for acronyms section in previous articles published by BMJ open. We defer to the editors if it is necessary. 4) I suggest minimizing the use of abbreviations and acronyms where possible. For example, sensitivity and specificity do not need abbreviations. Even things like LR and AUC could be avoided, without adding too much to the word count. With too many acronyms, the results become difficult to read. If you choose to keep your abbreviations, you need to define them in body of the manuscript, not just in the abstract.
Answer: For minimizing word count and simplifying, we choose to keep our abbreviations. All abbreviations and acronyms now have been defined in body of the manuscript when they are mentioned first time.
Reviewer: 3
Reviewer Name: Annalisa Perna, MSc The absence of study protocol and of prospective registration should still be described in more detail among the limitations of this meta-analysis.
Answer: We accept Prof Perna's suggestion. This point has been added into the limitation of the meta-analysis.
